<div>
  <ul>
    <li>
      <p>
        Massachusetts-based biotechnology company HotSpot Therapeutics has partnered with global data and analytics company Excelra to leverage the latter&rsquo;s Global Online Structure Activity Relationship Database (GOSTAR) platform to identify new drug targets. The terms and financial details of the partnership have not been disclosed.
      </p>
    </li>
    <li>
      <p>
        The partnership will integrate GOSTAR&rsquo;s comprehensive datasets, which include over eight million molecules and binding data, with Hotspot&rsquo;s AI/ML models to accelerate the discovery of novel allosteric targets and therapeutics.
      </p>
    </li>
  </ul>
  <p>
  </p>
</div>


<div>
  <p>
    <a href="https://www.prnewswire.com/news-releases/excelra-partners-with-hotspot-therapeutics-to-enhance-allosteric-drug-discovery-efforts-301555011.html">
      PR Newswire
    </a>
  </p>
</div>


All Updates

Hotspot Therapeutics partners with Excelra to enhance drug discovery

Caris Life Sciences partners HotSpot Therapeutics to develop precision medicine drugs and CDx tests

HotSpot Therapeutics raises USD 100 million oversubscribed Series C